188 related articles for article (PubMed ID: 15952911)
1. Refining an Alzheimer's vaccine to avoid an inflammatory response.
Brown ME; DaSilva KA; McLaurin J
Expert Opin Biol Ther; 2005 Jun; 5(6):809-16. PubMed ID: 15952911
[TBL] [Abstract][Full Text] [Related]
2. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
3. Vaccine trial in Alzheimer's disease is halted.
Marder K
Curr Neurol Neurosci Rep; 2003 Sep; 3(5):371-2. PubMed ID: 12914678
[No Abstract] [Full Text] [Related]
4. Immunotherapy for Alzheimer's disease.
Gelinas DS; DaSilva K; Fenili D; St George-Hyslop P; McLaurin J
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14657-62. PubMed ID: 15297619
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
6. [Aβ42 gene vaccine for prevention and treatment of Alzheimer's disease].
Rosenberg RN
Rinsho Shinkeigaku; 2010 Nov; 50(11):838. PubMed ID: 21921464
[No Abstract] [Full Text] [Related]
7. Alternative Abeta immunotherapy approaches for Alzheimer's disease.
Town T
CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):114-27. PubMed ID: 19355932
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
[TBL] [Abstract][Full Text] [Related]
9. Harnessing the immune system to battle Alzheimer's: some of the most promising approaches to fight Alzheimer's disease aim to develop vaccines.
Brower V
EMBO Rep; 2002 Mar; 3(3):207-9. PubMed ID: 11882536
[No Abstract] [Full Text] [Related]
10. Amyloid-beta immunotherapy for Alzheimer's disease.
Fu HJ; Liu B; Frost JL; Lemere CA
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):197-206. PubMed ID: 20205640
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
Li Y; Liu Y; Wang Z; Jiang Y
Expert Opin Biol Ther; 2013 Nov; 13(11):1515-22. PubMed ID: 24053611
[TBL] [Abstract][Full Text] [Related]
12. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
13. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.
Orgogozo JM; Gilman S; Dartigues JF; Laurent B; Puel M; Kirby LC; Jouanny P; Dubois B; Eisner L; Flitman S; Michel BF; Boada M; Frank A; Hock C
Neurology; 2003 Jul; 61(1):46-54. PubMed ID: 12847155
[TBL] [Abstract][Full Text] [Related]
14. Vaccines: chasing the dream.
Schnabel J
Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
[No Abstract] [Full Text] [Related]
15. 'Clinical trials in Alzheimer's disease': immunotherapy approaches.
Delrieu J; Ousset PJ; Caillaud C; Vellas B
J Neurochem; 2012 Jan; 120 Suppl 1():186-193. PubMed ID: 21883222
[TBL] [Abstract][Full Text] [Related]
16. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
[TBL] [Abstract][Full Text] [Related]
17. Safety, tolerability and immunogenicity of an active anti-Aβ
Lacosta AM; Pascual-Lucas M; Pesini P; Casabona D; Pérez-Grijalba V; Marcos-Campos I; Sarasa L; Canudas J; Badi H; Monleón I; San-José I; Munuera J; Rodríguez-Gómez O; Abdelnour C; Lafuente A; Buendía M; Boada M; Tárraga L; Ruiz A; Sarasa M
Alzheimers Res Ther; 2018 Jan; 10(1):12. PubMed ID: 29378651
[TBL] [Abstract][Full Text] [Related]
18. Vaccine development for Alzheimer's disease.
Dasilva KA; Aubert I; McLaurin J
Curr Pharm Des; 2006; 12(33):4283-93. PubMed ID: 17105428
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes.
Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL
Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509
[TBL] [Abstract][Full Text] [Related]
20. Novel Abeta immunogens: is shorter better?
Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
